Entvin (YC S22)’s Post

In the world of pharma, staying on top of regulatory and research updates is a constant challenge. It’s not just about finding changes; it’s about identifying those critical shifts that impact patient safety and compliance—an often time-consuming, manual task. At Entvin (YC S22), we’ve been working to transform this experience. Imagine you’re a regulatory affairs professional or scientist who’s used to sifting through endless documentation just to find one small update. Now, imagine if in a matter of minutes, an AI-driven tool pinpointed exactly where that change occurred. Take, for example, a critical update happened in this week for drug "Spravato" in the “Warnings and Precautions” section of an FDA label. This is usually like searching for a needle in a haystack. With Entvin AI, that “needle” is no longer lost—it’s instantly highlighted, ready for review. The impact? Less time spent searching, more confidence in compliance, and greater focus on advancing patient outcomes. It’s a small shift with a big difference, making it easier for professionals to stay informed and proactive. (Attached: A snapshot showing how Entvin’s platform highlights these crucial changes.)